Subsidiary25 May 2026, 03:39 pm
Lyka Labs: ₹2301.44 Lakhs Impairment on Lyka BDR Investment
AI Summary
Lyka Labs Ltd's board approved recognizing an impairment loss of ₹2301.44 Lakhs on its investment and loans to subsidiary Lyka BDR International Limited due to continuous operational losses and eroding net worth. The company's financial exposure in Lyka BDR stands at ₹2301.44 Lakhs, including equity investment of ₹1469.05 Lakhs and unsecured loan of ₹832.39 Lakhs. The board also approved audited financial results for the quarter and year ended March 31, 2026, and fixed June 04, 2026, as the record date for equity share allocation pursuant to the scheme.
Key Highlights
- Lyka Labs recognizes ₹2301.44 Lakhs impairment loss on Lyka BDR investment.
- Impairment due to Lyka BDR's operational losses and eroding net worth.
- Audited financial results for quarter and year ended March 31, 2026 approved.
- Record date fixed as June 04, 2026 for equity share allocation.
- 47th Annual General Meeting to be held on August 10, 2026.
Price Impact
More from LYKALABS